This week we highlight a new enhanced COVID-19 vaccine trial and the spin out of another major health care business. We also look at a Food and Drug Administration clearance for the smallest blood clot removal device and a company that raised $192 million based on a heart-attack-predicting software ... READ MORE >
FDA
5 things to know in life sciences: Week of June 27, 2022
This week we highlight actions by a U.S. Food and Drug Administration advisory panel deciding on what COVID-19 boosters should contain for this fall. The panel voted overwhelmingly to include updates for the omicron variant, setting up the potential that COVID-19 vaccines will be managed like the flu with ... READ MORE >
5 things to know in life sciences: Week of June 20, 2022
This week we highlight a new app that assists patients with Parkinson’s disease and a European trade organization that seeks help to address inflation concerns. In addition, a new contact lens designed to combat eye fatigue from digital devices receives regulatory approval and researchers identify a ... READ MORE >
5 things to know in life sciences: Week of June 13, 2022
Diagnosing some disorders in children present unique challenges. Now, companies are looking at using artificial intelligence to uncover subtle tools to help. We also look at a new report on diversity in the biotech industry, research into long COVID-19, and Food and Drug Administration site inspections. ... READ MORE >
5 things to know in life sciences: Week of June 6, 2022
Management of diabetes care has improved dramatically since the introduction of insulin pumps and continuous glucose monitoring. Now, companies are hopeful that an “artificial pancreas” is on the horizon, which would substantially improve the standard of care for this common disease. We also look at 3D ... READ MORE >
5 things to know in life sciences: Week of May 2, 2022
This week we highlight a series of moves by the Food and Drug Administration related to COVID-19 treatments, Alzheimer's and CBD. We also look at contract research organizations and a robotics manufacturing partnership in cell and gene therapy, as well as sentiment in the biotech funding space. Each week ... READ MORE >
5 things to know in life sciences: Week of April 18, 2022
This week we highlight new guidance from the U.S. Food and Drug Administration on ensuring that clinical trials are inclusive, Biogen’s challenges with marketing its new Alzheimer’s drug, a COVID-19 breathalyzer and how a new type of T cell could allow better targeting of solid tumors. Finally, we look at ... READ MORE >
5 things to know in life sciences: Week of March 28, 2022
This week we highlight a Food and Drug Administration approval for an alternative to LASIK, promising results for a less invasive brain interface device and a precision biotech who has recently raised an additional $100 million in funding. Finally, we look at additional FDA approvals for a wearable ... READ MORE >
5 things to know in life sciences: Week of March 7, 2022
This week we highlight changes in drug exclusivity, international mRNA manufacturing expansion, clinical trial challenges in Russia, and recent Food and Drug Administration activities. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Top 10 ... READ MORE >
5 things to know in life sciences: Week of Feb. 28, 2022
This week we highlight clinical holds on cell and gene therapies, clinical trials and patient experience, artificial intelligence and identifying bone fractures, and more. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Cell and gene therapies ... READ MORE >